tiprankstipranks
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
US Market
Holding VRTX?
Track your performance easily

Vertex Pharmaceuticals (VRTX) Financial Statements

5,811 Followers

Vertex Pharmaceuticals Financial Overview

Vertex Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.993; its P/E ratio is ―; Vertex Pharmaceuticals is scheduled to report earnings on February 11, 2025, and the estimated EPS forecast is $3.99. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 2.77B$ 2.65B$ 2.69B$ 2.52B$ 2.48B
Gross Profit$ 2.38B$ 2.27B$ 2.35B$ 2.15B$ 2.16B
EBIT$ 1.22B$ -3.38B$ 1.29B$ 1.16B$ 1.18B
EBITDA$ 1.22B$ -3.33B$ 1.34B$ 1.22B$ 1.22B
Net Income Common Stockholders$ 1.05B$ -3.59B$ 1.10B$ 968.80M$ 1.04B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.52B$ 5.80B$ 10.17B$ 11.22B$ 11.93B
Total Assets$ 22.24B$ 20.13B$ 23.92B$ 22.73B$ 21.73B
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 6.61B$ 5.36B$ 5.37B$ 5.15B$ 5.21B
Stockholders Equity$ 15.63B$ 14.77B$ 18.55B$ 17.58B$ 16.51B
Cash Flow-
Free Cash Flow-$ -3.82B$ 1.24B$ 118.50M$ 1.23B
Operating Cash Flow-$ -3.75B$ 1.31B$ 234.60M$ 1.27B
Investing Cash Flow-$ -463.70M$ -2.14B$ -886.50M$ -117.70M
Financing Cash Flow-$ -358.60M$ -357.50M$ -119.80M$ -165.00M
Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

Vertex Pharmaceuticals Debt to Assets

Vertex Pharmaceuticals Cash Flow

Vertex Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis